We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZIP:NYSEZipRecruiter, Inc. Analysis

Data as of 2026-05-12 - not real-time

$3.45

Latest Price

8/10Risk

Risk Level: High

Executive Summary

ZipRecruiter trades around $3.45, comfortably above its 20‑day SMA (≈$2.98) but well below the 200‑day SMA (≈$3.65), indicating a neutral trend. Technicals show a bullish MACD crossover (MACD line > signal) and a relatively high RSI at 66, suggesting limited upside momentum in the near term. The stock faces a strong resistance near $3.84 and solid support around $2.30, while volatility is extreme at ~89% and beta exceeds 2.5, underscoring a high‑risk price profile.
Fundamentally, the company reports a forward P/E of 8 versus an industry average of 17, implying potential undervaluation, yet it posts negative operating (‑1.4%) and profit margins (‑5.6%). Revenue slipped 2.3% YoY, but the newly launched AI matching engine boosted relevant applications by 37% and the “Be Seen First” feature drives higher employer engagement. Cash on hand ($393 M) exceeds debt ($557 M) but the balance sheet shows a negative book value per share, and no dividend is paid. Analyst consensus is a “hold” with a median price target of $3.50, aligning closely with the current price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI approaching overbought territory
  • Proximity to resistance at $3.84 limits upside
  • Elevated volatility and beta increase short‑term price swings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E of 8 vs industry 17 suggests valuation upside
  • AI engine rollout expected to improve job‑match efficiency and revenue
  • Improving product adoption metrics (Be Seen First) indicate growth potential

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Persistent negative operating margins raise profitability concerns
  • Strong cash position offsets debt but negative book value remains a red flag
  • High beta and volatility imply sustained price risk over longer horizons

Key Metrics & Analysis

Financial Health

Revenue Growth-2.30%
Profit Margin-5.58%
P/E Ratio8.0
ROA-0.85%
P/B Ratio-3.8
Op. Cash Flow$17.4M
Free Cash Flow$11.0M
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI66.3
Support$2.30
Resistance$3.84
MA 20$2.98
MA 50$2.53
MA 200$3.65
MACDBullish
VolumeIncreasing
Fear & Greed Index87.96

Valuation

Target Price$3.33
Upside/Downside-3.38%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.70
Volatility89.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.